59716-06-2 Usage
Description
()-4-benzhydryl-2-[(3,4-dimethoxyphenyl)methyl]-1,2-dimethylpiperazine, also known as BDMP, is a chemical compound belonging to the piperazine class of organic compounds. It is a derivative of piperazine with two benzhydryl groups at the 4 position and a 3,4-dimethoxyphenylmethyl group at the 2 position. BDMP is characterized by its unique chemical structure, which makes it a valuable target for further pharmacological research and drug development.
Uses
Used in Medicinal Chemistry:
BDMP is used as a potential antipsychotic agent in the field of medicinal chemistry. It has been studied for its potential use in the treatment of various psychiatric disorders and has shown promise in animal studies.
Used in Pharmaceutical Industry:
In the pharmaceutical industry, BDMP is used as a starting material for the synthesis of other compounds with potential therapeutic applications. Its unique chemical structure allows for the development of new drugs with improved efficacy and safety profiles.
Used in Drug Development:
BDMP is a valuable compound in drug development due to its potential as an antipsychotic agent. Researchers are actively investigating its pharmacological properties and exploring its potential use in the treatment of various psychiatric disorders, with the aim of developing new and effective medications for patients in need.
Check Digit Verification of cas no
The CAS Registry Mumber 59716-06-2 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,9,7,1 and 6 respectively; the second part has 2 digits, 0 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 59716-06:
(7*5)+(6*9)+(5*7)+(4*1)+(3*6)+(2*0)+(1*6)=152
152 % 10 = 2
So 59716-06-2 is a valid CAS Registry Number.
59716-06-2Relevant articles and documents
Piperazine compounds
-
, (2008/06/13)
Cardioactive 3-methyl-3-(3,4-dialkoxybenzyl)-piperazine compounds of the formula STR1 and their salts with physiologically tolerable acids; methods for making the same; pharmaceutical compositions containing the compounds as an active ingredient; and methods of treating cardiac diseases such as arrhythmia with said compounds.
